About this trial
To assess the improvement in sexual function and self-perceived quality of life using PROMs (Patient-Reported Outcomes) in patients treated for cervical cancer who undergo a multimodal intervention in the sexual sphere and lifestyle compared to those who undergo care within routine clinical practice.
Eligibility criteria
Qualifiers
Women of legal age.
Patients with primary cervical cancer stage FIGO I-III (initial or locally advanced) of squamous histology, adenocarcinoma or adenosquamous.
Patients treated for cancer with surgery and/or radiotherapy ± systemic treatment in the Gynaecological Oncology Units of hospitals in Spain.
Complete response after oncospecific treatment was obtained.
Disqualifiers
Patients under 18 years of age.
Pregnancy or breastfeeding.
Partial response after completion of oncospecific treatment.
Patients with premalignant pathology.
Trial design
Treatments tested in this trial
- Sex hormones and modulators of the genital system.